CAIRO:– In line with Egypt's drive to confront population growth and boost family planning, PHARCO will launch a new company, specialized in the manufacturing of women's medicines, i.e. birth control pills and healthcare hormones for women of all ages.
The new state-of-the-art company, the first of its kind in Egypt, will mark a milestone in PHARCO's history of looking after the Egyptian family and society as a whole.
“The group is launching a new company specialized in the production of medicines for women driven by our commitment to this nation and to contribute to the mitigation of the negative impacts of population growth and to rein in the depletion of Egypt's economic resources," said Dr. Sherine Helmy, Deputy Chairman & Managing Director of PHARCO Group.
Last year, the Ministry of Health and Population launched "Operation Lifeline", a strategy to reduce the birthrate to 2.4, saving the government up to EGP 200 billion (around $ 11.2 billion) by 2030.
The launch of the new company to produce medicines for women comes within the framework of a strategy, initiated by President Abdel Fattah El Sisi, for the advancement of Egyptian women, as one half of our society and a pillar for state development plans.
"We have faith in the importance of women in our society and their key role in the advancement of our nation socially, economically and politically. Therefore, we will launch the first company in Egypt with state-of-the-art technology to produce hormone treatments and other drugs of the world's top quality for the best interest of women and the Egyptian society," Dr. Helmy added.
It's noteworthy that PHARCO Group was established 30 years ago by the group's Chairman Dr. Hassan Abbas Helmy, who has founded a successful group of healthcare producers in Egypt and the Middle East.
© Press Release 2018